Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk inthe presence of potent P2Y12 receptor antagonists?
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk inthe presence of potent P2Y12 receptor antagonists?
1693-1694
Warner, T.D.
552d97b9-d533-4cd5-a3e6-f3f89ab69608
Armstrong, P.C.
6c168c00-3234-49a8-b645-bdb8eba2772b
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4
Mitchell, J.A.
c8dcd7ae-ba34-4714-9d6f-19fbfd1f400a
2010
Warner, T.D.
552d97b9-d533-4cd5-a3e6-f3f89ab69608
Armstrong, P.C.
6c168c00-3234-49a8-b645-bdb8eba2772b
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4
Mitchell, J.A.
c8dcd7ae-ba34-4714-9d6f-19fbfd1f400a
Warner, T.D., Armstrong, P.C., Curzen, N. and Mitchell, J.A.
(2010)
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk inthe presence of potent P2Y12 receptor antagonists?
Heart, 96 (21), .
(doi:10.1136/hrt.2010.205724).
This record has no associated files available for download.
More information
Published date: 2010
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 355228
URI: http://eprints.soton.ac.uk/id/eprint/355228
PURE UUID: 6d3885f1-e5a2-487c-bcaf-38038689d9a5
Catalogue record
Date deposited: 06 Aug 2013 15:05
Last modified: 15 Mar 2024 03:23
Export record
Altmetrics
Contributors
Author:
T.D. Warner
Author:
P.C. Armstrong
Author:
J.A. Mitchell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics